Edward Hurwitz's Net Worth
Estimate Recalculated Nov 7, 2024 05:11PM EST
Who is Edward Hurwitz
Edward Hurwitz does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include COTHERIX INC, NeurogesX Inc, Cara Therapeutics, Inc., MACROGENICS INC, Dyne Therapeutics, Inc., APPLIED GENETIC TECHNOLOGIES CORP, THRESHOLD PHARMACEUTICALS INC, TURMERIC ACQUISITION CORP., SUNESIS PHARMACEUTICALS INC, TorreyPines Therapeutics, Inc., and Aegerion Pharmaceuticals, Inc..
SEC CIK
Edward Hurwitz's CIK is 0001211840
Past Insider Trading and Trends
2018 was Edward Hurwitz's most active year for acquiring shares with 4 total transactions. Edward Hurwitz's most active month to acquire stocks was the month of April. 2022 was Edward Hurwitz's most active year for disposing of shares, totalling 10 transactions. Edward Hurwitz's most active month to dispose stocks was the month of October. 2023 saw Edward Hurwitz paying a total of $73,650.00 for 63,400 shares, this is the most they've acquired in one year. In 2022 Edward Hurwitz cashed out on 109,935 shares for a total of $0.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
